Results 181 to 190 of about 96,603 (330)

Diversity of Gut Microbiota and Metabolites in Benign Prostatic Hyperplasia with Different Prostate Volumes. [PDF]

Eur Urol Open Sci
Liu J, Chen Y, Wang Y, Li D, Xu Z, Zhang J, Qin L, Han B, Jing Y, Cui D, Zhu Y, Xia S, Jiang C.   +12 more
europepmc   +1 more source

A prospective, randomizised clinical trial comparing holmium laser enucleation versus photoselective vaporization for day-surgery to treat benign prostatic hyperplasia

, 2020
Y.B. Chen, Q. Chen, Meng Gu, C. Liu, Z. Wang   +4 more
openalex   +1 more source

Mixed Gonadal Dysgenesis: A Comprehensive Review of Clinical Spectrum, Diagnostic Strategies, and Management Approaches

Clinical Endocrinology, Volume 104, Issue 2, Page 92-102, February 2026.
ABSTRACT Background Mixed gonadal dysgenesis (MGD) is a rare form of differences in sex development (DSD) typically associated with 45,X/46,XY mosaicism. The phenotypic presentation of MGD varies from atypical genitalia to typical male or female appearances often associated with Turner stigmata.
Dinesh Giri, Sushil Yewale, Hannah Hickingbotham, Cara Williams, Mohamed Shalaby, Julie Alderson, Julie Park   +6 more
wiley   +1 more source

A Case Series on the Efficacy and Safety of Transperineal Laser Ablation for Benign Prostatic Hyperplasia. [PDF]

J Clin Med
Locke MR, Locke DR.
europepmc   +1 more source

FREQUENCY OF INCIDENTAL CARCINOMA PROSTATE IN PATIENTS WITH CLINICALLY BENIGN PROSTATIC HYPERPLASIA

, 2020
Muhammad Naeem, Rizwan Ullah, Muhammad Izhar, Muhammad Irfan, Riaz Khan   +4 more
openalex   +1 more source

Quantifying stent‐induced dose perturbations in intravascular brachytherapy using 3D‐ printed phantoms and film dosimetry

Journal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Background Coronary artery disease (CAD), the leading cause of death worldwide, is the narrowing of coronary arteries due to atherosclerotic plaque buildup. A common treatment for CAD is percutaneous coronary intervention (PCI), often involving stent placement. However, a common complication or in‐stent restenosis (ISR) can occur in 10%–20% of
Jessica S. Jung, Lyu Huang, Nicholas Coupera, Yijian Cao, Jenghwa Chang   +4 more
wiley   +1 more source

Preliminary clinical outcomes of irreversible electroporation in the management of prostatic hyperplasia. [PDF]

Medicine (Baltimore)
Yu Z, Wen Q, Guo Y, Chen L, Wang Y, Hang G, Chen B.   +6 more
europepmc   +1 more source

Circadian Rhythms in Urology: Bridging Benign Prostatic Hyperplasia and Cardiovascular Disease Risk

Yu-Hsiang Lin, Po Ting Lin, Kuo Jen Lin
openalex   +2 more sources

Basal cell hyperplasia (BCH) versus high grade prostatic intraepithelial neoplasia (HGPIN) in tiny prostatic needle biopsies: Unusual diagnostic dilemma

, 2013
Fatma El‐Zahraa Salah El‐Deen Yassin, Eman Salah, Mohamed A. Zaki, Mohammed D. Saleem, Rabab Ahmed Ahmed Mohammed   +4 more
openalex   +1 more source

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

Advanced Functional Materials, Volume 36, Issue 1, 2 January 2026.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth, Neal I. Callaghan, Locke Davenport Huyer   +2 more
wiley   +1 more source